DFSVX
Price
$48.41
Change
-$0.04 (-0.08%)
Updated
Nov 19 closing price
Net Assets
15.71B
RYPNX
Price
$15.95
Change
+$0.02 (+0.13%)
Updated
Nov 19 closing price
Net Assets
1.02B
Interact to see
Advertisement

DFSVX vs RYPNX

Header iconDFSVX vs RYPNX Comparison
Open Charts DFSVX vs RYPNXBanner chart's image
DFA US Small Cap Value I
Price$48.41
Change-$0.04 (-0.08%)
VolumeN/A
Net Assets15.71B
Royce Small-Cap Opportunity Invmt
Price$15.95
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets1.02B
DFSVX vs RYPNX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. RYPNX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a Hold and RYPNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 15.7B vs. RYPNX (1.02B). DFSVX pays higher dividends than RYPNX: DFSVX (1.69) vs RYPNX (0.00). DFSVX was incepted earlier than RYPNX: DFSVX (33 years) vs RYPNX (29 years). RYPNX (1.22) is less costly to investors than DFSVX (0.31). RYPNX is a more actively managed with annual turnover of: 35.00 vs. DFSVX (12.00). DFSVX has a lower initial minimum investment than RYPNX: DFSVX (0) vs RYPNX (2000). DFSVX annual gain was more profitable for investors over the last year : -3.00 vs. RYPNX (-4.20). DFSVX return over 5 years is better than : 61.32 vs. RYPNX (13.93).
DFSVXRYPNXDFSVX / RYPNX
Total Expense Ratio0.311.2225%
Annual Report Gross Expense Ratio0.311.2225%
Fund Existence33 years29 years-
Gain YTD1.1592.97039%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets15.7B1.02B1,539%
Annual Yield % from dividends1.690.00-
Returns for 1 year-3.00-4.2071%
Returns for 3 years17.3810.38167%
Returns for 5 years61.3213.93440%
Returns for 10 years53.4630.95173%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELMD25.210.69
+2.81%
Electromed
MLTX13.550.15
+1.12%
MoonLake Immunotherapeutics
MPLX53.320.45
+0.85%
Mplx LP
VRAR1.04N/A
N/A
Glimpse Group (The)
NAMS38.62-0.29
-0.75%
NewAmsterdam Pharma Company NV